Scott Kahan, MD
MPH, Johns Hopkins Univ
MD, Medical College of Pennsylvania
Scott Kahan, M.D., M.P.H. is a physician trained in both clinical medicine and public health. His clinical practice specializes in weight management and obesity medicine, and he serves as Director of the National Center for Weight and Wellness. Dr. Kahan also works as a public health physician specializing in obesity and preventive medicine. He serves as the Medical Director for the George Washington University-based Strategies to Overcome and Prevent (S.T.O.P.) Obesity Alliance, a coalition of more than 90 organizations that drive innovative and practical strategies to address obesity. He serves as Chair of the Clinical Committee for The Obesity Society, and serves on the Board of Directors for the American Board of Obesity Medicine.
He teaches several courses on obesity, nutrition, public health, and health behavior change to medical students, graduate students, and undergraduate students. He has published 15 books in the fields of medicine, nutrition, and public health, and is the Editor-in-Chief of a series of medical texts that have been published internationally and translated into nine foreign languages. He co-authored a nutrition handbook for physicians, which is distributed free-of-charge to medical students in North America. His most recent textbook, published by Johns Hopkins University Press, is Health Behavior Change in Populations: The State of the Evidence and Roles for Key Stakeholders. He serves as a scientific peer-reviewer for more than 30 academic journals and research organizations, and he has advised the White House, U.S. Congress, FDA, several Surgeons General, and other decision-making organizations.
Honors and Awards
Patients' Choice Award for Top Doctors, 2010-2016
40 under 40 award, Drexel University
Healthcare Provider Advocate of the Year (2015), OAC
Outstanding Contribution, Academy of Nutrition and Dietetics
Dr. Kahan has participated in research focused on obesity treatment and prevention, nutrition interventions for chronic disease, and public health prevention.
- Kahan S, Ferguson C, David S, Divine L. Obesity drug outcome measures: Results of a multi-stakeholder critical dialogue. Curr Obes Rep 2013;2(2):128-133.
- Cheskin LJ, Kahan S, Shantha GP. Intentional weight loss and dose reductions of antihypertensive medications: a retrospective cohort study. CardioRenal Medicine 2013;3:17-25.
- Shantha GP, Kumar AA, Kahan S, Cheskin LJ. Association between glycosylated hemoglobin and intentional weight loss in overweight and obese patients with type 2 diabetes mellitus: a retrospective cohort study. Diabetes Educ. 2012;38(3):417-26.
- Kumar AA, Shantha GP, Kahan S, Samson RJ, Boddu ND, Cheskin LJ. Intentional weight loss and dose reductions of anti-diabetic medications – a retrospective cohort study. PLoS One. 2012;7(2): e32395.
- Kahan S, Freedhoff Y. Interventions to reduce or modify dietary fat reduce cardiovascular events. Ann Intern Med. 2012;156(2):JC1-4,JC15.